Source:http://linkedlifedata.com/resource/pubmed/id/10508115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1999-10-21
|
pubmed:abstractText |
At present, immunophenotyping of hematological malignancies represents one of the most relevant clinical applications of flow cytometry. In recent years, its use has extended from clinical research to diagnostic laboratories. The aim of this report is to critically review the type of information provided by the flow cytometric immunophenotyping of hematological malignancies and its clinical impact as well as to highlight its potential future applications.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1708-17
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
|
pubmed:affiliation |
Department of Medicine and Centro de Investigaciones del Cancer, Universidad de Salamanca, 37007 Salamanca, Spain. orfao@gugu.usal.es
|
pubmed:publicationType |
Journal Article,
Review
|